These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37449493)

  • 1. Dipeptidase‑2 is a prognostic marker in lung adenocarcinoma that is correlated with its sensitivity to cisplatin.
    Wang Y; Zhang T; Du H; Yang M; Xie G; Liu T; Deng S; Yuan W; He S; Wu D; Xu Y
    Oncol Rep; 2023 Aug; 50(2):. PubMed ID: 37449493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of Linc00173 increases BCL2 mRNA stability via the miR-1275/PROCA1/ZFP36L2 axis and induces acquired cisplatin resistance of lung adenocarcinoma.
    Tao X; Li Y; Fan S; Wu L; Xin J; Su Y; Xian X; Huang Y; Huang R; Fang W; Liu Z
    J Exp Clin Cancer Res; 2023 Jan; 42(1):12. PubMed ID: 36627670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated Single-Cell and Transcriptome Sequencing Analyses Identify Dipeptidase 2 as an Immune-Associated Prognostic Biomarker for Lung Adenocarcinoma.
    Zhang X; Zhang Y; Gao X; Zhang Y; Chen Y
    Pharmaceuticals (Basel); 2023 Jun; 16(6):. PubMed ID: 37375818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-DPA1 overexpression inhibits cancer progression, reduces resistance to cisplatin, and correlates with increased immune infiltration in lung adenocarcinoma.
    Shi K; Li QY; Zhang YQ; Huang H; Ding DX; Luo WM; Zhang J; Guo Q
    Aging (Albany NY); 2023 Oct; 15(20):11067-11091. PubMed ID: 37899135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EZH2 as a prognostic-related biomarker in lung adenocarcinoma correlating with cell cycle and immune infiltrates.
    Fan K; Zhang BH; Han D; Sun YC
    BMC Bioinformatics; 2023 Apr; 24(1):149. PubMed ID: 37069494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of eIF6 as a prognostic factor that drives tumor progression and predicts arsenic trioxide efficacy in lung adenocarcinoma.
    Shen Y; Zhang R; Li X
    Mol Biol Rep; 2023 Feb; 50(2):1167-1180. PubMed ID: 36435920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SNHG15 enhances cisplatin resistance in lung adenocarcinoma by affecting the DNA repair capacity of cancer cells.
    Li Y; Huang HQ; Huang ZH; Yu ND; Ye XL; Jiang MC; Chen LM
    Diagn Pathol; 2023 Mar; 18(1):33. PubMed ID: 36864456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SERPINB5 is a prognostic biomarker and promotes proliferation, metastasis and epithelial-mesenchymal transition (EMT) in lung adenocarcinoma.
    He X; Ma Y; Huang Z; Wang G; Wang W; Zhang R; Guo G; Zhang X; Wen Y; Zhang L
    Thorac Cancer; 2023 Aug; 14(23):2275-2287. PubMed ID: 37424293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An immune indicator based on BTK and DPEP2 identifies hot and cold tumors and clinical treatment outcomes in lung adenocarcinoma.
    Han T; Liu Y; Wu J; Bai Y; Zhou J; Hu C; Zhang W; Guo J; Wang Q; Hu D
    Sci Rep; 2023 Mar; 13(1):5153. PubMed ID: 36991102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Interaction of Calcium-Sensing Receptor with KIF11 Enhances Cisplatin Resistance in Lung Adenocarcinoma via BRCA1/cyclin B1 pathway.
    Wang F; Fu X; Chang M; Wei T; Lin R; Tong H; Zhang X; Yuan R; Zhou Z; Huang X; Zhang W; Su W; Lu Y; Liang Z; Zhang J
    Int J Biol Sci; 2024; 20(10):3892-3910. PubMed ID: 39113697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CEACAM6 promotes cisplatin resistance in lung adenocarcinoma and is regulated by microRNA-146a and microRNA-26a.
    Du H; Li Y; Sun R; Yuan Y; Sun S; Zhang Y
    Thorac Cancer; 2020 Sep; 11(9):2473-2482. PubMed ID: 32648688
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Wang Z; Zhou L; Chen B; Li X; Zou Q; Xu W; Fang L; Wu A; Li Z; Chen Y
    Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-375 promotes cisplatin sensitivity of lung adenocarcinoma.
    Du S; Qu H; Zhang Y; Zhu S; Wang Y; Zhang S; Wang Z; Yang Q; Fu S; Dong K
    Pathol Res Pract; 2023 Sep; 249():154765. PubMed ID: 37625279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation.
    Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J
    BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction and validation of a prognostic model for lung adenocarcinoma based on endoplasmic reticulum stress-related genes.
    Li F; Niu Y; Zhao W; Yan C; Qi Y
    Sci Rep; 2022 Nov; 12(1):19857. PubMed ID: 36400857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of replication protein A 3 induces protective autophagy and enhances cisplatin sensitivity in lung adenocarcinoma by inhibiting AKT/mTOR signaling via binding to cyclin-dependent kinases regulatory subunit 2.
    Chen L; Hu K; Liu Y; Liu L; Tang J; Qin X
    Drug Dev Res; 2022 Nov; 83(7):1589-1599. PubMed ID: 35903032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High expression of keratin 6C is associated with poor prognosis and accelerates cancer proliferation and migration by modulating epithelial-mesenchymal transition in lung adenocarcinoma.
    Hu HB; Yang XP; Zhou PX; Yang XA; Yin B
    Genes Genomics; 2020 Feb; 42(2):179-188. PubMed ID: 31768767
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Jiang F; Shen Q; Zhang F; Fu J; Hu L; Wang J; Zhou H; Chen J; Wang Y
    DNA Cell Biol; 2022 Jun; 41(6):631-640. PubMed ID: 35612423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the fatty acid metabolism-related genes in lung adenocarcinoma to guide clinical therapy.
    Huang G; Zhang J; Gong L; Wang X; Zhang B; Liu D
    BMC Pulm Med; 2022 Dec; 22(1):486. PubMed ID: 36564744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Actin-like protein 8 promotes cell proliferation, colony-formation, proangiogenesis, migration and invasion in lung adenocarcinoma cells.
    Ma S; Wang X; Zhang Z; Liu D
    Thorac Cancer; 2020 Mar; 11(3):526-536. PubMed ID: 31962007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.